Quantification of in vitro and in vivo angiogenesis stimulated by ovine forestomach matrix biomaterial

Biomaterials

Volumn 32, Issue 27, 2011, Pages 6351-6361

  Irvine, Sharleen M ^a,b   Cayzer, Juliet ^c   Todd, Elise M ^a   Lun, Stan ^a   Floden, Evan W ^a   Negron, Leonardo ^a   Fisher, James N ^a   Dempsey, Sandi G ^a   Alexander, Alan ^c   Hill, Michael C ^e   O'Rouke, Annalee ^f   Gunningham, Sarah P ^d   Knight, Cameron ^g   Davis, Paul F ^b,f   Ward, Brian R ^a   May, Barnaby C H ^a  

^a Mesynthes Limited   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c Estendart Ltd   (New Zealand)

^d UNIVERSITY OF OTAGO   (New Zealand)

^e WAIKATO DISTRICT HEALTH BOARD   (New Zealand)

^f Trinity Bioactives Ltd   (New Zealand)

^g MASSEY UNIVERSITY   (New Zealand)

Author keywords

Angiogenesis; Animal model; Bioactivity; ECM (extracellular matrix); Growth factors; Scaffold

Indexed keywords

ANGIOGENESIS; ANIMAL MODEL; BRANCH POINTS; CELL ACTIVITY; CHICKEN CHORIOALLANTOIC MEMBRANES; COLLAGEN MATRICES; DECELLULARIZED; ECM (EXTRACELLULAR MATRIX); GROWTH FACTORS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; IN-VITRO; MATRIX; NATIVE EXTRACELLULAR MATRIX; SMALL INTESTINAL SUBMUCOSA; TISSUE REGENERATION; VASCULOGENESIS;

ADHESION; ANIMALS; BIOACTIVITY; BIOMIMETICS; BLOOD; CELL ADHESION; ENDOTHELIAL CELLS; REFORESTATION; TISSUE;

BLOOD VESSELS;

BIOMATERIAL; BIOMIMETIC MATERIAL; OVINE FORESTOMACH MATRIX; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; BLOOD VESSEL; CELL ADHESION; CELL COMMUNICATION; CELL MIGRATION; CHICKEN; CHORIOALLANTOIS; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; FORESTOMACH; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; TISSUE REGENERATION; UMBILICAL VEIN ENDOTHELIAL CELL; WOUND;

ANIMALS; AORTA; BIOCOMPATIBLE MATERIALS; BIOLOGICAL ASSAY; CELL MOVEMENT; CELL PROLIFERATION; CHICKENS; CHORIOALLANTOIC MEMBRANE; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; REGENERATION; SHEEP; STOMACH; UMBILICAL VEINS;

ANIMALIA; OVIS; SPONDIAS PURPUREA; SUS;

EID: 79960092487     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.05.040     Document Type: Article

References (39)

1. Laschke M.W., Harder Y., Amon M., Martin I., Farhadi J., Ring A., et al. Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes. Tissue Eng 2006, 12:2093-2104.
2. Menon N.G., Rodriguez E.D., Byrnes C.K., Girotto J.A., Goldberg N.H., Silverman R.P. Revascularization of human acellular dermis in full-thickness abdominal wall reconstruction in the rabbit model. Ann Plast Surg 2003, 50:523-527.
3. Milburn M.L., Holton L.H., Chung T.L., Li E.N., Bochicchio G.V., Goldberg N.H., et al. Acellular dermal matrix compared with synthetic implant material for repair of ventral hernia in the setting of peri-operative staphylococcus aureus implant contamination: a rabbit model. Surg Infect (Larchmt) 2008, 9:433-442.
4. Franklin M.E., Trevino J.M., Portillo G., Vela I., Glass J.L., Gonzalez J.J. The use of porcine small intestinal submucosa as a prosthetic material for laparoscopic hernia repair in infected and potentially contaminated fields: long-term follow-up. Surg Endosc 2008, 22:1941-1946.
5. Wainwright D.J. Use of an acellular allograft dermal matrix (AlloDerm) in the management of full-thickness burns. Burns 1995, 21:243-248.
6. Badylak S.F. The extracellular matrix as a biologic scaffold material. Biomaterials 2007, 28:3587-3593.
7. Badylak S.F., Freytes D.O., Gilbert T.W. Extracellular matrix as a biological scaffold material: structure and function. Acta Biomater 2009, 5:1-13.
8. Lun S., Irvine S.M., Johnson K.D., Fisher N.J., Floden E.W., Negron L., et al. A functional extracellular matrix biomaterial derived from ovine forestomach. Biomaterials 2010, 31:4517-4529.
9. Badylak S.F., Gilbert T.W. Immune response to biologic scaffold materials. Semin Immunol 2008, 20:109-116.
10. Hodde J.P., Record R.D., Liang H.A., Badylak S.F. Vascular endothelial growth factor in porcine-derived extracellular matrix. Endothelium 2001, 8:11-24.
11. Hodde J.P., Ernst D.M., Hiles M.C. An investigation of the long-term bioactivity of endogenous growth factor in OASIS wound matrix. J Wound Care 2005, 14:23-25.
12. McDevitt C.A., Wildey G.M., Cutrone R.M. Transforming growth factor-beta1 in a sterilized tissue derived from the pig small intestine submucosa. J Biomed Mater Res A 2003, 67:637-640.
13. Voytik-Harbin S.L., Brightman A.O., Kraine M.R., Waisner B., Badylak S.F. Identification of extractable growth factors from small intestinal submucosa. J Cell Biochem 1997, 67:478-491.
14. Beattie A.J., Gilbert T.W., Guyot J.P., Yates A.J., Badylak S.F. Chemoattraction of progenitor cells by remodeling extracellular matrix scaffolds. Tissue Eng Part A 2009, 15:1119-1125.
15. Reing J.E., Zhang L., Myers-Irvin J., Cordero K.E., Freytes D.O., Heber-Katz E., et al. Degradation products of extracellular matrix affect cell migration and proliferation. Tissue Eng Part A 2009, 15:605-614.
16. Floden E.W., Malak S.F., Basil-Jones M.M., Negron L., Fisher J.N., Lun S., et al. Biophysical characterization of ovine forestomach extracellular matrix biomaterials. J Biomed Mater Res B Appl Biomater 2010, 96:67-75.
17. Jaffe E.A., Nachman R.L., Becker C.G., Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973, 52:2745-2756.
18. Franchitto A., Pichierri P., Mosesso P., Palitti F. Caffeine effect on the mitotic delay induced by G2 treatment with UVC or mitomycin C. Mutagenesis 1998, 13:499-505.
19. Nicosia R.F., Ottinetti A. Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro. Lab Invest 1990, 63:115-122.
20. Prophet E.B. Laboratory methods in histotechnology 1994, American Registry of Pathology, Washington, D.C.
21. Meyer W., Kacza J., Zschemisch N.H., Godynicki S., Seeger J. Observations on the actual structural conditions in the stratum superficiale dermidis of porcine ear skin, with special reference to its use as model for human skin. Ann Anat 2007, 189:143-156.
22. Yen A., Braverman I.M. Ultrastructure of the human dermal microcirculation: the horizontal plexus of the papillary dermis. J Invest Dermatol 1976, 66:131-142.
23. Nicosia R.F., Villaschi S. Rat aortic smooth muscle cells become pericytes during angiogenesis in vitro. Lab Invest 1995, 73:658-666.
24. Colton C.K. Implantable biohybrid artificial organs. Cell Transplant 1995, 4:415-436.
25. Yang B., Zhou L., Sun Z., Yang R., Chen Y., Dai Y. In vitro evaluation of the bioactive factors preserved in porcine small intestinal submucosa through cellular biological approaches. J Biomed Mater Res A 2010, 93:1100-1109.
26. Li F., Li W., Johnson S., Ingram D., Yoder M., Badylak S. Low-molecular-weight peptides derived from extracellular matrix as chemoattractants for primary endothelial cells. Endothelium 2004, 11:199-206.
27. Petter-Puchner A.H., Fortelny R.H., Walder N., Mittermayr R., Ohlinger W., van Griensven M., et al. Adverse effects associated with the use of porcine cross-linked collagen implants in an experimental model of incisional hernia repair. J Surg Res 2008, 145:105-110.
28. Auerbach R., Lewis R., Shinners B., Kubai L., Akhtar N. Angiogenesis assays: a critical overview. Clin Chem 2003, 49:32-40.
29. Prevel C.D., Eppley B.L., Summerlin D.J., Sidner R., Jackson J.R., McCarty M., et al. Small intestinal submucosa: utilization as a wound dressing in full-thickness rodent wounds. Ann Plast Surg 1995, 35:381-388.
30. Anderson J.M., Rodriguez A., Chang D.T. Foreign body reaction to biomaterials. Semin Immunol 2008, 20:86-100.
31. Hodde J., Hiles M. Bioactive FGF-2 in sterilized extracellular matrix. Wounds 2001, 13:195-201.
32. D'Angelo G., Struman I., Martial J., Weiner R.I. Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin. Proc Natl Acad Sci U S A 1995, 92:6374-6378.
33. Tepper O.M., Capla J.M., Galiano R.D., Ceradini D.J., Callaghan M.J., Kleinman M.E., et al. Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells. Blood 2005, 105:1068-1077.
34. Slevin M., West D., Kumar P., Rooney P., Kumar S. Hyaluronan, angiogenesis and malignant disease. Int J Cancer 2004, 109:793-794. author reply 5-6.
35. Gao F., Liu Y., He Y., Yang C., Wang Y., Shi X., et al. Hyaluronan oligosaccharides promote excisional wound healing through enhanced angiogenesis. Matrix Biol 2010, 29:107-116.
36. West D.C., Hampson I.N., Arnold F., Kumar S. Angiogenesis induced by degradation products of hyaluronic acid. Science 1985, 228:1324-1326.
37. Agrawal V., Johnson S.A., Reing J., Zhang L., Tottey S., Wang G., et al. Epimorphic regeneration approach to tissue replacement in adult mammals. Proc Natl Acad Sci U S A 2010, 107:3351-3355.
38. Shepherd B.R., Enis D.R., Wang F., Suarez Y., Pober J.S., Schechner J.S. Vascularization and engraftment of a human skin substitute using circulating progenitor cell-derived endothelial cells. FASEB J 2006, 20:1739-1741.
39. Suh W., Kim K.L., Kim J.M., Shin I.S., Lee Y.S., Lee J.Y., et al. Transplantation of endothelial progenitor cells accelerates dermal wound healing with increased recruitment of monocytes/macrophages and neovascularization. Stem Cells 2005, 23:1571-1578.